Thursday, May 25, 2017

Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data

http://ift.tt/2rWXFIz

Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study DataKey highlights in the biotech sector include FDA approval for Regeneron’s (REGN) Kevzara and data from Amgen and Celgene.

May 25, 2017 at 09:22AM

http://ift.tt/2qYMjX6

from

http://ift.tt/2qYMjX6


at

No comments:

Post a Comment